Page 67 - EJMO-9-3

Eurasian Journal of
Medicine and Oncology An update on SLE

9. Pertschuk LP, et al. Acute pulmonary complications in 21. Lee YJ, Park JA, Kwon H, et al. Role of stem cell-like
systemic lupus erythematosus. Immunofluorescence and light memory T cells in systemic lupus erythematosus. Arthritis
microscopic study. Am J Clin Pathol. 1977;68(5):553-557. Rheumatol. 2018;70(9):1459-1469.
doi: 10.1093/ajcp/68.5.553 doi: 10.1002/art.40524
10. Delaney P. Neurologic complications of systemic lupus 22. Fischer-Betz R, Herzer P, Schneider M. Systemic lupus
erythematosus. Am Fam Physician. 1983;28(1):191-193. erythematosus. Dtsch Med Wochenschr. 2005;130(43):2451-
8; quiz 2459-60, 2461-2.
11. Mukherjee S. Long term complications in systemic lupus
erythematosus. J Assoc Physicians India. 2006;54 Suppl:22-26. 23. Ichikawa Y. Diagnosis and clinical symptoms of systemic
lupus erythematosus and overlap syndrome. Nihon Naika
12. Moore JE, Shulman LE, Scott JT. The natural history of
systemic lupus erythematosus: An approach to its study Gakkai Zasshi. 1990;79(10):1360-1365.
through chronic biologic false positive reactors: Interim 24. Horiuchi A. Diagnosis and therapy of systemic lupus
report. Trans Am Clin Climatol Assoc. 1956;68:59-67; erythematosus. Nihon Naika Gakkai Zasshi. 1993;82(3):381-5.
discussion 67-8.
25. Allard SA, Charles PJ, Herrick AL, McColl KE, Scott JT.
13. Mak A, Cheung MW, Chiew HJ, Liu Y, Ho RC. Global trend Antinuclear antibodies and the diagnosis of systemic lupus
of survival and damage of systemic lupus erythematosus: erythematosus in patients with acute intermittent porphyria.
Meta-analysis and meta-regression of observational Ann Rheum Dis. 1990;49(4):246-248.
studies from the 1950s to 2000s. Semin Arthritis Rheum. doi: 10.1136/ard.49.4.246
2012;41(6):830-839.
26. Ho, A, Magder LS, Barr SG, Petri M. Decreases in anti-
doi: 10.1016/j.semarthrit.2011.11.002
double-stranded DNA levels are associated with concurrent
14. Yen EY, Shaheen M, Woo JM, et al. 46-year trends in systemic flares in patients with systemic lupus erythematosus.
lupus erythematosus mortality in the United States, 1968 Arthritis Rheum. 2001;44(10):2342-2349.
to 2013: A nationwide population-based study. Ann Intern doi: 10.1002/1529-0131(200110)44:10<2342:aid-art397>3.0.co;2-8
Med. 2017;167(11):777-785.
27. Smeenk R, Brinkman K, Van den Brink H, et al. Antibodies
doi: 10.7326/M17-0102
to DNA in patients with systemic lupus erythematosus. Their
15. Brinks R, Fischer-Betz R, Sander O, Richter JG, Chehab G, role in the diagnosis, the follow-up and the pathogenesis of
Schneider M. Age-specific prevalence of diagnosed systemic the disease. Clin Rheumatol. 1990;9(1 Suppl):100-110.
lupus erythematosus in Germany 2002 and projection to doi: 10.1007/BF02205557
2030. Lupus. 2014;23(13):1407-1411.
28. Ho A, Barr SG, Magder LS, Petri M. A decrease in complement
doi: 10.1177/0961203314540352
is associated with increased renal and hematologic activity
16. Danchenko N, Satia JA, Anthony MS. Epidemiology of in patients with systemic lupus erythematosus. Arthritis
systemic lupus erythematosus: A comparison of worldwide Rheum. 2001;44(10):2350-2357.
disease burden. Lupus. 2006;15(5):308-318.
doi: 10.1002/1529-0131(200110)44:10<2350:aid-art398>3.0.co;2-a
doi: 10.1191/0961203306lu2305xx
29. Tunnicliffe DJ, Singh-Grewal D, Kim S, Craig JC, Tong A.
17. Wegman ME. Definition of mortality. Pediatrics. Diagnosis, monitoring, and treatment of systemic
1968;41(4):854-855. lupus erythematosus: A systematic review of clinical
practice guidelines. Arthritis Care Res (Hoboken).
18. Kan HJ, Song X, Johnson BH, Bechtel B, O’Sullivan D,
Molta CT. Healthcare utilization and costs of systemic 2015;67(10):1440-1452.
lupus erythematosus in Medicaid. Biomed Res Int. doi: 10.1002/acr.22591
2013;2013:808391.
30. Alabduljabbar K, Alkhalifah M, Aldheshe A, et al.
doi: 10.1155/2013/808391 Development of a cardiovascular disease risk prediction
model: A preliminary retrospective cohort study of a patient
19. Urowitz MB, Gladman DD. How to improve morbidity and
mortality in systemic lupus erythematosus. Rheumatology sample in Saudi Arabia. J Clin Med. 2023;12(15):5115.
(Oxford). 2000;39(3):238-244. doi: 10.3390/jcm12155115
doi: 10.1093/rheumatology/39.3.238 31. Tash AA, Al-Bawardy RF. Cardiovascular disease in Saudi
Arabia: Facts and the way forward. J Saudi Heart Assoc.
20. Ling GS, Crawford G, Buang N, et al. C1q restrains
autoimmunity and viral infection by regulating CD8(+) T 2023;35(2):148-162.
cell metabolism. Science. 2018;360(6388):558-563. doi: 10.37616/2212-5043.1336
doi: 10.1126/science.aao4555 32. Alenzi EO, Fatima W, Amara A, et al. A systematic review of

Volume 9 Issue 3 (2025) 59 doi: 10.36922/EJMO025090042